Symtuza
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.symtuza.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Symtuza
Janssen Pharmaceuticals offers SYMTUZA, an effective once-daily treatment for HIV, combining darunavir, cobicistat, emtricitabine, and tenofovir alafenamide. The product is aimed at patients either newly diagnosed or switching treatments, ensuring an approachable solution to maintaining an undetectable viral load. The company provides extensive resources including patient support, cost assistance, and educational tools tailored to enhance patient experience and treatment adherence. Janssen CarePath is available to assist patients in navigating their insurance options and accessing necessary support.Explore more
Popular SearchesSymtuzaSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Symtuza your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Symtuza is spiking on competitors!
Funding: Get notified immidiatlly once Symtuza has new funding data
Congratulate Masked Content for being promoted to Masked Content at Symtuza
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Symtuza recently announced quarterly report
Check if Symtuza has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Symtuza launches new products
Click to see if Symtuza had a recent Job posting/layoffs
Symtuza, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Symtuza
Find 2 more new buyers
Compare Similar Companies to Symtuza
Compare insights from companies similar to Symtuza, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Symtuza
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Symtuza is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Symtuza is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Symtuza.
Symtuza Tech Stack
A closer look at the technologies used by Symtuza
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Symtuza
Sign Up For FreeTo access detailed company insights
Janssen Pharmaceuticals offers SYMTUZA, an effective once-daily treatment for HIV, combining darunavir, cobicistat, emtricitabine, and tenofovir alafenamide. The product is aimed at patients either newly diagnosed or switching treatments, ensuring an approachable solution to maintaining an undetectable viral load. The company provides extensive res... Read More
